Stock Analysis
- Poland
- /
- Personal Products
- /
- WSE:MIR
Miraculum Full Year 2023 Earnings: zł0.041 loss per share (vs zł0.065 loss in FY 2022)
Miraculum (WSE:MIR) Full Year 2023 Results
Key Financial Results
- Revenue: zł47.1m (up 8.7% from FY 2022).
- Net loss: zł1.64m (loss narrowed by 33% from FY 2022).
- zł0.041 loss per share (improved from zł0.065 loss in FY 2022).
All figures shown in the chart above are for the trailing 12 month (TTM) period
Miraculum shares are down 5.5% from a week ago.
Risk Analysis
Don't forget that there may still be risks. For instance, we've identified 3 warning signs for Miraculum (1 makes us a bit uncomfortable) you should be aware of.
Valuation is complex, but we're helping make it simple.
Find out whether Miraculum is potentially over or undervalued by checking out our comprehensive analysis, which includes fair value estimates, risks and warnings, dividends, insider transactions and financial health.
View the Free AnalysisHave feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
About WSE:MIR
Miraculum
Miraculum S.A., a cosmetics company, develops and markets face and body care, perfume, depilation, and make-up products for men and women in Poland and internationally.
Slightly overvalued with worrying balance sheet.